Arc­turus takes an­oth­er le­gal stab at for­mer CEO as pub­lic bat­tle turns se­ri­ous for the com­pa­ny

The bit­ter and pub­lic feud be­tween small RNA med­i­cines com­pa­ny Arc­turus Ther­a­peu­tics $ARCT and its for­mer CEO Joe Payne is rag­ing on Fri­day, with a brand new law­suit (yes, an­oth­er one) launched against Payne and a few of his as­so­ciates.

In the law­suit, Arc­turus al­leges that Payne and his as­so­ciates Bradley Soren­son, Pe­ter Far­rell, and An­drew Sas­sine (col­lec­tive­ly re­ferred to as “the Payne group”) have failed to file cer­tain pa­per­work with the SEC. Specif­i­cal­ly, the law­suit ac­cus­es the group for mul­ti­ple vi­o­la­tions of fed­er­al dis­clo­sure and re­port­ing rules un­der Sec­tion 13(d) of the Ex­change Act and Reg­u­la­tion 13D.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER